"Thymoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed)
Descriptor ID |
D013945
|
MeSH Number(s) |
C04.557.435.850 C04.588.894.949.500 C15.604.861.800
|
Concept/Terms |
Carcinoma, Thymic- Carcinoma, Thymic
- Carcinomas, Thymic
- Thymic Carcinoma
- Thymic Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Thymoma".
Below are MeSH descriptors whose meaning is more specific than "Thymoma".
This graph shows the total number of publications written about "Thymoma" by people in this website by year, and whether "Thymoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 1 | 2 |
1999 | 2 | 0 | 2 |
2001 | 0 | 1 | 1 |
2003 | 2 | 0 | 2 |
2014 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thymoma" by people in Profiles.
-
The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma. J Thorac Oncol. 2017 04; 12(4):734-744.
-
All that wheezes is not asthma: cognitive bias in pediatric emergency medical decision making. Pediatr Emerg Care. 2014 Feb; 30(2):104-7.
-
Thymoma and multiple malignancies: a case of five synchronous neoplasms and literature review. Clin Med Res. 2003 Jul; 1(3):227-32.
-
Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2). Vaccine. 2003 Jun 02; 21(19-20):2318-28.
-
Sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and enhances the antigen-specific T-cell response. J Immunother. 2001 Sep-Oct; 24(5):420-9.
-
Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination. Clin Cancer Res. 1999 May; 5(5):1173-82.
-
TNFA and TNFB polymorphisms in myasthenia gravis. Arch Neurol. 1999 Apr; 56(4):457-61.
-
Intestinal pseudo-obstruction as a paraneoplastic manifestation of malignant thymoma. Am J Gastroenterol. 1997 Sep; 92(9):1564-6.
-
Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. Autoimmunity. 1997; 26(2):111-6.
-
Immunoglobulin allotypes in myasthenia gravis patients with a thymoma. J Autoimmun. 1990 Jun; 3(3):299-305.